terol 7a-hydroxylase gene and additional activators of RLD-1 and OR-1 are closely related orphan nuclear the oxysterol types, among which 24(S),25-epoxychoreceptors that can be activated by certain oxysterols. lesterol and 24(S)-hydroxycholesterol were most poTo obtain cells stably expressing RLD-1 or OR-1, tent. As these oxysterols can activate LXRa/b at physi-CHOK1 cells were successively transfected with a ological concentrations, the activation of LXR by oxy-DGRE2-ALP reporter and GR-RLD-1 or GR-OR-1 chi-sterols was proposed to be a new hormonal signaling meric constructs. The selected cell clones that showed pathway that may play a critical role in the regulation low background activity of the reporter and maximum of cholesterol homeostasis, e.g. via LXRa acting as an ways. We therefore established cell clones stably exwas inhibited by H-89 and bisindolylmaleimide, both inhibitors of protein kinases. These results suggest pressing chimeric constructs of these receptors along that transactivation by ligand-activated RLD-1 may be with a suitable reporter gene construct. Upon screening further modulated/regulated through other signal of various compounds we observed that agents trigtransduction pathways involving phosphorylation cat-gering other signal transduction pathways markedly alyzed by protein kinases. ᭧ 1998 Academic Press enhanced the activation of RLD-1 by 22R(OH)cholesterol and that this enhancement could be abolished by the addition of protein kinase inhibitors such as H-89 and BIM. The nuclear receptor LXRa/RLD-1(1, 2), and its close relative LXRb/OR-1(also described as UR/NER/RIP MATERIALS AND METHODS 15)(3-6) are orphan members of the nuclear receptor superfamily. They were shown to form heterodimers Plasmids. The chimeric receptor constructs were generated by with RXR that bind to a DR-4 type responsive element, replacing the natural DNA binding domain of OR-1 or RLD-1 with the glucocorticoid receptor DBD employing suitable restriction sites conferring constitutive transcriptional activation and/ or PCR mutagenesis. The GR-OR-1 construct contains aa1-75 of ORor enhanced response to the RXR ligand 9-cis retinoic 1 fused in frame to aa419-500 of the GR-DBD followed by aa163-446 acid (1-3, 5,6).
and the putative influence of other signalling pathskolin in cells expressing GR-RLD-1. The enhancement ways. We therefore established cell clones stably exwas inhibited by H-89 and bisindolylmaleimide, both inhibitors of protein kinases. These results suggest pressing chimeric constructs of these receptors along that transactivation by ligand-activated RLD-1 may be with a suitable reporter gene construct. Upon screening further modulated/regulated through other signal of various compounds we observed that agents trigtransduction pathways involving phosphorylation cat-gering other signal transduction pathways markedly alyzed by protein kinases. ᭧ 1998 Academic Press enhanced the activation of RLD-1 by 22R(OH)cholesterol and that this enhancement could be abolished by the addition of protein kinase inhibitors such as H-89 and BIM. The nuclear receptor LXRa/RLD-1(1, 2), and its close relative LXRb/OR-1(also described as UR/NER/RIP MATERIALS AND METHODS 15)(3-6) are orphan members of the nuclear receptor superfamily. They were shown to form heterodimers Plasmids. The chimeric receptor constructs were generated by with RXR that bind to a DR-4 type responsive element, replacing the natural DNA binding domain of OR-1 or RLD-1 with the glucocorticoid receptor DBD employing suitable restriction sites conferring constitutive transcriptional activation and/ or PCR mutagenesis. The GR-OR-1 construct contains aa1-75 of OR- or enhanced response to the RXR ligand 9-cis retinoic 1 fused in frame to aa419-500 of the GR-DBD followed by aa163-446 acid (1-3, 5,6).
of OR-1. The GR-RLD-1 construct contains aa1-93 of RLD-1 fused
In an attempt to find potential activators, Janowski to aa419-500 of GR-DBD followed by aa180-455 of RLD-1. The correct et al. identified a specific subset of oxysterols that acti-in frame fusions were confirmed by sequencing. Both constructs were subcloned in the pCMX vector yielding the pCMX-GR-OR-1 and the vate LXRa in CV-1 cell cotransfection assays (7).
pCMV-GR-RLD-1 expression vectors, respectively.
Among them, 22R(OH)cholesterol showed the highest
The pMSG vector from Pharmacia was used for the construction activation potential. Furthermore Lehmann et al.(8) of the reporter, DGRE2-ALP, where the major GRE sites in MMTV identified an LXR response element in the rat choles-have been replaced by one single GRE cloned between a Cla I and Sac I site. The sequence of the inserted GRE is: (upper strand) 5-CGAT AGAACA CAG TGTTCT GAGCT-and (lower strand) 5-C AGAACA CTG TGTTCT TA-3. The secretable form of ALP (human 1 Current address: Department of Agricultural Chemistry, National Taiwan University, Taipei, Taiwan.
placental alkaline phophatase cDNA) was cloned as described by 0006-291X/98 $25.00
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Berger et al. (9) and inserted. The MMTV sequence 5 of the Sac I site has been deleted but the sequence between the Sac I site and the insertion comes from MMTV, i.e. the GRE 1 2 site, the NF-1 and Oct-1 binding sites including the TATA binding region and part of the MMTV leader sequence is included in this construct.
Cell culture and stable transfection. CHO K1 cells were maintained in Ham's F-12 medium (SVA, Uppsala, Sweden) supplemented with 10% fetal calf serum (Gibco BRL.). For stable transfections, cells were seeded at a density of 25,000 cells/cm 2 on 6 cm round plates in 5 mL medium and grown for 24 h. Transfections were performed with lipofectamine (Gibco BRL) according to the manufacturer's instructions. Each plate received 3 mg of DGRE2-ALP and 0.3 mg psV Neo. Transfected cells were selected in the presence of 0.8 mg/mL medium of G418 (10) . The colonies grown were pooled to form a reporter clone mix. The expression of the DGRE2-ALP in this reporter clone mix was confirmed by the induction of the ALP enzyme by dexamethasone after transient transfection with pMT-GR (11). The reporter clone mix was further transfected with GR-RLD-1 or GR-OR-1 expression vectors (1 or 5 mg/plate) together with pKSV Hygro (0.1 or 0.5 mg/plate respectively) (12) and selected with 0.8 mM hygromycin. Fifty clones were picked from each plate, expanded and tested for their responsiveness to 5 mM 22R(OH)cholesterol, the known activator of hLXRa. The clone that showed maximum fold signalling pathways we tested several compounds known to act as second messengers and/or to activate protein kinases. Treatment of the cells stably express-RESULTS ing GR-RLD-1 with various concentrations of PGE 2 alone did not induce reporter gene activity ( Fig. 2A) . Prior to the stable transfection procedure, the inducHowever, when these cells were treated with increastion of GR-RLD-1 and GR-OR-1 by 22R(OH)cholesterol ingly amounts of PGE 2 in the presence of 5 mM on the DGRE2-ALP reporter was confirmed in tran-22R(OH)cholesterol, the basal level of induction by 5 sient co-transfection experiments (data not shown).
mM of 22R(OH)cholesterol alone was raised with inThe dose-response curve of three selected clones to creasing concentrations of PGE 2 to more than 3-fold 22R(OH)cholesterol is shown in Fig. 1 . Cells stably ex-( Fig. 2A) . Similar treatment of the cells with increasing pressing the GR-RLD-1 chimera were more responsive concentrations of 22R(OH)cholesterol in the presence to 22R(OH)cholesterol than cells expressing the GRof 50 mM PGE 2 markedly increased the induction of the OR-1 chimera that was only very moderately induced reporter gene activity compared to those induced by (1.5 fold induction at 5 mM). The maximum induction 22R(OH)cholesterol alone (Fig. 3) . No enhancing effects of the GR-RLD-1 clone was achieved at the concentration of 25 mM 22R(OH)cholesterol resulting in a 12.5 of PGE 2 were seen when the concentrations of 22R (OH)cholesterol were too low to be active, i.e., lower mM concentrations (Fig. 2C) . The cAMP analogue 8-bromo-cAMP also showed an enhancing effect but at than 1 mM (Fig. 3) .
As PGE 2 is known to act through PKA or PKC de-much higher concentrations (Fig. 2D) . The synergistic effects of these agents were not observed with pendent signalling mediated by membrane receptors (13) we decided to test other agents triggering these the reporter clone mix or cell clones stably expressing GR-OR-1 (Figs. 4 and 5) . pathways. In a way similar to PGE 2 , although at much lower concentrations, TPA, a phorbol ester that
The agents tested are known to activate protein kinase A and/or protein kinase C. To investigate if the activates protein kinase C, enhanced the activity of the reporter in the presence of RLD-1 up to 4-5 fold synergistic effect observed is related to phosphorylation events catalysed by these protein kinases, inhibicompared to 22R(OH)cholesterol alone (Figs. 2B and  3) . In a corresponding experiment with increasing tors of these enzymes were added to cultured cells treated with 22R(OH)cholesterol and the various efamounts of 22R(OH)cholesterol in the presence of a fixed concentration of 10 nM TPA, an up to 4-fold fectors. The synergistic activation by PGE 2 and TPA was completely inhibited by 6 mM of Bisindolylmaleiinduction was achieved (Fig. 3) . Forskolin, an activator of adenylate cyclase, could enhance the activation mide I (BIM). (Fig. 5 A,B) . However, this concentration of BIM only partially inhibited the synergistic effects to an even higher extent, i.e. up to 15 fold at 50-100 that is not present in the LBD fusions used by other groups. The PEST sequences in the OR-1 N-terminus might render the receptor protein more susceptible for proteolysis and thus result in a shorter-half life.
The synergistic effects of PGE 2 , TPA, forskolin and 8-bromo-cAMP on the activation of RLD-1 by 22R(OH)-cholesterol are evident from the results of induction experiments that either fixed the concentration of the activator and varied the concentration of the synergistic effector or vice versa. With the exception of forskolin, the three remaining effectors alone did not activate the receptors.
Forskolin may activate the adenylate cyclase pathway resulting in elevated cAMP levels which in turn may lead to elevated PKA activity. Treatment of cells with forskolin alone not only induced reporter gene activity in the cell clone expressing GR-RLD-1, but also activated the cell clone expressing GR-OR-1 and the reporter clone mix to an extent comparable to or even greater than 22R(OH)cholesterol (Fig. 4C ). This induction was abolished almost completely by H-89, which is a PKA specific inhibitor at the concentration used. Moreover, 1,9-dideoxy-forskolin, a structural analogue almost complete elimination of the effect of forskolin by the addition of 6 mM of H-89. Since the Ki values of H-89 for PKA and PKC are 48 nM and 31.7 mM, respectively, PKA is presumably almost completely inhibited of forskolin and 8-bromo-cAMP. On the other hand, Hat a 6 mM concentration of H-89 while PKC is only 89 inhibited the synergistic effects of PGE 2 and Forpartially affected. Furthermore, the forskolin mediated skolin to almost 100%, in contrast to the less complete effect was only partially abolished by the addition of 2 inhibition on the enhancing effects of TPA and 8-mM BIM. The Ki values of BIM for the inhibition of bromo-cAMP (Fig. 4) .
PKA and PKC are 2 mM and 10 nM, respectively. With 2 mM of BIM, therefore, PKC is presumably almost DISCUSSION completely inhibited while PKA is only partially affected. In this study, we established cell clones according to the inducibility of reporter gene activity by 22R(OH)-As expected, the enhancement mediated by TPA, a PKC activator, was only partially abolished by 6 mM cholesterol, a known activator of LXRs. The EC 50 value of 22R(OH)cholesterol activation of GR-RLD-1 found of H-89 in contrast to the almost complete inhibition when BIM was added to the medium. Considering the in this study was 5.4 mM and is comparable to the results from previous transient-transfection studies low concentrations used(10 nM), TPA showed the strongest effect on reporter gene activation in the GRvarying from 1.5 mM (Janowski et al., 1996) to more than 10 mM as reported by Lehmann et al. (1997) . How-RLD-1 expressing cells. Interestingly, RLD-1 contains a putative recognition sequence for PKC (RXXSXR) in ever, cell clones stably expressing GR-OR-1 chimera responded to 22R(OH)cholesterol very poorly which is the hinge region of the protein at aa225-230 (RSFSDR) in contrast to OR-1 that does not contain a similar site. in contrast to data presented by Lehmann et al.(1997) where hLXRb, the human analogue of rat OR-1, was Cells expressing this chimera were not affected by TPA treatment. activated to a greater extent by 22R(OH)cholesterol than was hLXRa(RLD-1). One possible explanation
The enhancing effect of PGE 2 on the activation of GR-RLD-1 was almost completely inhibited by both could be that the GR-OR-1 construct used in this study includes the N-terminus of OR-1, a part of the protein the 6 mM H-89 and 2 mM BIM treatment. The effects of PGE 2 on cells and tissues are diverse and sometimes can be activated through phosphorylation by a mitogen-activated protein kinase (16) . Phosphorylation of even opposite. This diversity is due to the various PGE 2 receptor subtypes (EPs) being coupled to a variety of thyroid hormone receptor (TRb1) resulted in enhanced dimerization (17) with RXR and tissue specific stabilisignal transduction pathways, including PKA and PKC (13) . It is not clear if one or more EP subtypes are zation (18). Phosphorylation of the MAPK site in the A/B region of PPARg inhibited both ligand-indepenexpressed in the CHO K1 cells used in this study.
The results of this study imply that the transactiva-dent and ligand-dependent transactivation functions (19) . Phosphorylation of Ser-350 of the orphan nuclear tion of LXRa/RLD-1 may be further modulated/regulated by mechanisms involved in signal transduction receptor NGFI-B resulted in a decrease in binding to the NGFI-B response element (20, 21). pathways, such as phosphorylation associated with protein kinases. The modulation/regulation of the tranThe oxysterols that activate LXR seem to occur at the rate-limiting steps of cholesterol metabolism such scription activity by phosphorylation has been demonstrated in other nuclear receptors previously. For as: steroid hormone biosynthesis, bile acid biosynthesis and conversion of lanosterol to cholesterol. LXRa is example, the orphan nuclear receptor steroidogenic factor-1 (SF-1) has been shown to regulate the cAMP-specifically expressed in tissues that are metabolically active, such as liver and adrenal gland. It is therefore mediated transcription of cytochrome P450 steroid hydroxylase genes (14) and to be activated synergistically possible that activation of LXRa by oxysterols may lead to transcriptional regulation of crucial metabolic pathby phorbol esters (15) . The human estrogen receptor 
